share_log

中国抗体-B(03681):刘文溢辞任非执行董事

China antibody-B (03681): Director Liu Wenyi resigns as non-executive director

Zhitong Finance ·  Sep 27, 2024 19:01

China Antibody-B (03681) announced that Director Liu Wenyi has already submitted his resignation as a non-executive director, effective from September 2024...

Finance and Economics APP News, China Antibody-B (03681) announced that Director Liu Wenyi has already submitted his resignation as a non-executive director, effective from September 26, 2024, in order to devote more time to personal affairs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment